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Abstract 
Alcohol consumption during pregnancy remains common in many countries. Exposure 
to even low amounts of alcohol (ie ethanol) in pregnancy can result in the 
heterogeneous fetal alcohol spectrum disorders (FASD), while heavy alcohol 
consumption can result in the fetal alcohol syndrome (FAS). FAS is characterised by 
cerebral dysfunction, growth restriction and craniofacial malformations. However, the 
effects of lower doses of alcohol during pregnancy, such as those that lead to FASD, 
are less well understood. In this article, we discuss the findings of recent studies 
performed in our laboratories on the effects of fetal alcohol exposure using sheep, in 
which we studied the effects of late gestational alcohol exposure on the developing 
brain, arteries, kidneys, heart and lungs. Our studies indicate that alcohol exposure in 
late gestation can (1) affect cerebral white matter development and increase the risk of 
hemorrhage in the fetal brain, (2) cause left ventricular hypertrophy with evidence of 
altered cardiomyocyte maturations, (3) lead to a decrease in nephron number in the 
kidney, (4) cause altered arterial wall stiffness and endothelial and smooth muscle 
function, and (5) result in altered surfactant protein mRNA expression, surfactant 
phospholipid composition and pro-inflammatory cytokine mRNA expression in the lung. 
These findings suggest that alcohol exposure in late gestation can affect multiple 
organs, potentially increasing the risk of disease and organ dysfunction in later life. 
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Introduction 
In this short review, we provide a summary of our recent findings from a series of 
related studies in sheep. In these studies we assessed fetal and early postnatal 
functional and structural effects on several organs of repeated maternal administration 
of alcohol (ie ethanol) during the third-trimester-equivalent of gestation. We have 
focused on organs that are likely susceptible to fetal alcohol exposure and that could 
result in developmental programming for later onset disease. Organs studied were the 
brain, heart, kidney, lung and arteries. We address the potential role of fetal alcohol 
exposure in developmental programming of postnatal health and disease, and suggest 
new avenues of research in this field. 
 
Incidence of fetal alcohol spectrum disorders  
Substantial numbers of infants are exposed to alcohol before birth. Recent surveys 
show that ~30% of women in the U.S.A(1) and ~60% of women in Australia(2) drink 
alcohol at some point during their pregnancy. Alcohol consumption is typically highest 
during the first trimester with less consumed as the pregnancy progresses; however 3% 
of women in the U.S.A consume alcohol throughout pregnancy(1). These statistics are of 
concern because maternal consumption of alcohol during pregnancy can result in a 
spectrum of developmental defects in the offspring referred to collectively as fetal 
alcohol spectrum disorders (FASD). The incidence of FASD is 20-50(3) and 9(4) per 
1,000 live births in the U.S.A and Canada respectively, but these rates may be under-
estimated due to the reliance on mothers to self-report alcohol consumption; detection 
of fatty acid ethyl esters in meconium may be a more objective measure of prenatal 
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alcohol exposure(5). The most severe manifestation of FASD is the fetal alcohol 
syndrome (FAS) which is caused by repeated, heavy alcohol consumption during 
pregnancy. FAS is diagnosed by a triad of birth defects: growth restriction (pre- and 
post-natal), craniofacial dysmorphology, and central nervous system (CNS) 
dysfunction(6). The incidence of FAS ranges from 2-7 per 1,000 live births in the 
U.S.A.(3), but is highest in South Africa where it has been reported to be 68-83 per 1,000 
live births(7).  
 
Pre- and post-natal growth restriction 
The developmental programming of adult-onset diseases, such as cardiovascular 
disease, due to low birth weight is now well-documented and accepted as a clinically 
important phenomenon(8). Alcohol exposure during gestation can cause low birth 
weight(9) which can arise due to intrauterine growth restriction (IUGR)(10, 11) and/or 
preterm birth(12, 13). Prolonged alcohol exposure (>10g alcohol or 0.7 U.S.A standard 
drinks per day) during early or late gestation may increase the risk of IUGR(10, 11). 
Prenatal alcohol exposure also results in postnatal growth restriction in offspring(14, 15) 
with reductions in body weight and height still evident in some individuals at 20 years of 
age(16).  
Animal studies indicate that alcohol exposure can restrict fetal and/or postnatal growth 
depending on the degree of  exposure. For example, in sheep daily self-administered 
alcohol exposure throughout gestation can cause IUGR(17), whereas our own studies 
showed that prolonged, daily exposure in late gestation does not induce IUGR(18), but 3 
days of alcohol exposure in late gestation apparently reduced fetal body weight(19). In 
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rats, alcohol exposure throughout pregnancy (20% alcohol, 80% liquid diet) and 
lactation was associated with a reduction in postnatal growth, despite a normal birth 
weight (20). Similarly, a mouse model of fetal alcohol exposure showed that mice born 
with a normal birth weight were growth restricted from 3 to 5 weeks postnatal age 
despite cross-fostering(21). In Japanese medaka fish (Oryzias latipes), alcohol exposure 
can reduce head width at any point during gestation, however reductions in body length 
occur only following alcohol exposure in early or late gestation(22). Together these 
findings suggest that there are many variables, such as the duration, gestational timing 
and maximal level of alcohol exposure, which can affect fetal and postnatal growth. 
Fetal growth restriction caused by gestational exposure to alcohol is characterized by 
reduced body fat stores(23) and/or the number and type of skeletal muscle fibres(24); 
these effects may be regulated by changes in insulin-like growth factors (IGFs). 
Increased or decreased levels of both IGF-1 and IGF-2 in offspring have been 
documented(25-30). The reason for this variability in IGF levels following prenatal alcohol 
exposure is likely due to species differences in animal models used (ie human, rat, 
sheep). Differences in maximal blood alcohol concentration or the gestational age at the 
time of exposure may also be contributing factors, as there is little consistency between 
studies in the procedures used to expose offspring to alcohol. Increased oxidative 
stress may also contribute to alcohol-induced fetal growth restriction, as administration 
of anti-oxidative peptides (NAPVSIPQ and SALLRSIPA) can alleviate fetal growth 
restriction in alcohol-exposed pregnant mice(31).  
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Vascularisation and growth of the placenta are important for maintaining fetal growth, 
and several studies suggest that the placenta may be highly susceptible to alcohol 
exposure. For example, during human pregnancies, consuming more than 5 U.S.A. 
standard drinks per week doubles the risk of placental-associated syndromes, defined 
as the incidence of placental abruption, placental previa, preeclampsia, small for 
gestational age, preterm birth or stillbirth(32). Studies in rats show that daily alcohol 
exposure (1 g and 5 g / kg of maternal weight) throughout pregnancy can cause 
irregular placental vascularisation(33) and that alcohol-induced growth restriction is 
associated with increases in placental weight(34). A combination of alcohol and tobacco 
smoke exposure in pregnant rats produced decreased placental weight, altered 
placental histology, including an increased number of hemorrhages, and delayed fetal 
development, but the changes in fetal and placental growth were reversed by the 
concurrent administration of sodium ferulate, an antioxidant used to treat vascular 
disease(35). Alcohol-induced IUGR may therefore be mediated, in part, by effects on 
placental growth and aberrant vascularisation. The placental effects of alcohol in 
inducing IUGR deserve further study. 
 
Alcohol-related birth defects  
The incidence of fetal structural malformations or alcohol-related birth defects (ARBD) is 
increased by prenatal alcohol exposure. Cardiac malformations, most commonly atrial 
and ventricular septal defects(6, 36), occur in ~20% of individuals exposed to alcohol in 
utero compared with 1.2% in control populations(37, 38). In FAS or FASD, a range of 
distinct facial anomalies is common: these include a smooth philtrum (the medial cleft 
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between nose and upper lip), malformed noses (small, upturned, cleft and flat nasal 
bridge), “railtrack” ears, narrow ear canals, prominent/deformed pinna and otosclerosis 
(bone overgrowth in the middle ear) and ocular defects such as microphthalmos (small 
eyes), epicanthus (skin fold over the upper eyelid) and strabismus (crossed eyes)(39, 40). 
Other malformations include kidney defects, such as renal hypoplasia, urethral 
obstructions and hydronephrosis(41, 42).  
 
Alcohol-related neurodevelopmental disorders  
In children, gestational alcohol exposure has been associated with decreased IQ, 
learning disabilities, memory impairment, visuo-spatial deficits, delayed language and 
motor development and increased risk of attention-deficit hyperactivity disorder(43-46). 
Prenatal alcohol exposure can affect multiple brain regions and functions, and can 
cause alterations in brain mass and neuronal organisation during development(47, 48). 
CNS dysfunction is a pre-requisite for the diagnosis of FAS and alcohol-related 
neurodevelopmental disorder (ARND), and is believed to be a result of CNS injury, 
although not all animal studies have detected clear evidence of brain damage in the 
fetus or neonate(18). Alcohol-induced brain injury can vary from none to extreme and 
may, in part, be due to genetic differences, which can influence the susceptibility of the 
brain to alcohol-induced injury(49).  
 
Maternal alcohol exposure in late gestation using a sheep model 
Experimental studies of fetal alcohol exposure vary widely in terms of the dose, the 
temporal pattern (e.g. binge or acute) and duration of exposure, the gestational age of 
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the offspring and the animal model used. Although several species have been used for 
studying the developmental effects of gestational alcohol exposure(50), the sheep has 
numerous advantages, especially for physiological studies, over other species including 
rodents. Sheep have a long gestation (~147 days), give birth to one or two offspring that 
have a similar body weight and gestational ontogeny of major organs to humans, and 
have a non-reactant uterus that allows surgical implantation of probes and catheters 
that permit physiological monitoring of the intact fetus in utero. The pharmacokinetics, 
including distribution and biotransformation, of alcohol in the maternal-fetal unit are 
similar for ovine and human pregnancies(51). Maternal-fetal weight of sheep is also 
similar to that of humans.  
Animal studies are necessarily limited in terms of recreating a realistic model of human 
alcohol consumption, primarily because human alcohol intake during pregnancy is 
highly variable between subjects.  Furthermore, nutritional deficits or alcohol tolerance 
may be observed in humans following chronic alcohol consumption prior to pregnancy, 
which is difficult to recreate in animal models. Therefore, our model of alcohol exposure 
did not attempt to mimic a common pattern of human alcohol consumption, but instead 
investigated the effects that may occur following alcohol exposure during latter 
pregnancy.  We chose to expose fetuses to alcohol during the last trimester equivalent, 
as this is when key maturational processes occur in the fetus, such as white matter 
development in the brain(52), nephrogenesis in the kidney(53), maturation of 
cardiomyocytes(54), and maturation of the gas-exchanging region and surfactant system 
in the lung(55, 56).  
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Alcohol was administered intravenously to pregnant ewes at either 1 g or 0.75 g/kg 
maternal body weight over 1 hour (h), which gave a maximal plasma alcohol (ethanol) 
concentration (PEC) of 110-120 mg/dL in the ewe (range: 0.10-0.13 g/dL, coefficient of 
variation (CV): 0.11) and fetus (range: 0.09-0.12 g/dL, CV: 0.12) (Fig 1); this equates to 
~3-4 standard U.S.A drinks ingested over 1h. The change in alcohol dose (from 1 g/kg 
to 0.75 g/kg) was made following the end of our first study, wherein our infusion protocol 
was improved and the alcohol dose lowered to maintain a similar maximal PEC across 
the studies. Maternal and fetal PEC reached similar peak values at the same time, and 
declined at approximately the same rate, indicating the rapid, bidirectional transfer of 
alcohol between the maternal and fetal circulations. Virtually all alcohol had been 
eliminated from maternal and fetal plasma by 8 h after the daily infusion onset. It is likely 
that maternal hepatic biotransformation of alcohol to acetaldehyde and acetate is the 
major mechanism for alcohol elimination from the maternal-fetal unit(51). Alcohol was 
infused into the maternal jugular vein so that PEC could be reliably controlled.  
Our laboratory has conducted three different experiments on the fetal and postnatal 
effects of fetal alcohol exposure during the third trimester-equivalent (Fig 2). The first of 
these examined the effects of administrating alcohol for 1 h per day to the pregnant ewe 
from 116-118 days of gestation age (DGA) on the fetal brain at 123 DGA (0.84 of 
term)(19). The second study examined a longer period of maternal alcohol exposure with 
pregnant ewes exposed to alcohol infusions for 1 h per day from 95-133 DGA and fetal 
brain, lungs, kidneys, heart and small arteries examined at 134 DGA (0.9 of term)(18, 57-
59); alcohol infusions were stopped at 133DGA due to the risk of pre-term birth(12). The 
third study examined the effects of this long alcohol exposure regimen used in our 
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second study on postnatal outcomes; that is, fetuses exposed to alcohol for 1 h per day 
from 95-133 DGA were allowed to be born naturally, and were then studied at nine 
weeks of age(60). The duration of exposure and the PEC were similar between all three 
studies and the experiments were performed at the same facility, using the same 
equipment, and in sheep from the same supplier.  
 
The effects of daily 1h exposure for three days  
In this study, we exposed 8 fetuses to a daily 1 h alcohol infusion (1 g/kg) for three 
days, from 116-118 DGA, via the maternal jugular vein; 8 control fetuses received saline 
infusion(19, 27). The maximal fetal and maternal PEC of 0.11+/-0.01 g/dL were reached at 
one hour after the start of the infusion. Fetal tissue was collected at 123 DGA, five days 
after the last alcohol infusion. Alcohol infusions did not affect fetal arterial partial 
pressure of oxygen (PaO2) or carbon dioxide (PaCO2), arterial saturation of oxygen 
(SaO2), pH, blood glucose concentration or mean arterial pressure (MAP)(19). Pro-
inflammatory cytokines, interleukin 1β (IL-1β), interleukin 6 (IL-6) and tumor necrosis 
factor-α (TNF-α) were also measured in fetal plasma, but their concentrations were 
similar to controls(19). At necropsy, a mean decrease of 500g (19%) in body weight was 
seen in alcohol-exposed fetuses compared with controls(27). There was a transient 
decrease in plasma IGF-1 in ewes at 30 h and IGF-2 in fetuses from 24-54 h after the 
first alcohol infusion, which could account for the decrease in fetal body weight(27).  
The fetal brain was examined with particular emphasis on white matter development 
that occurs in late gestation in sheep(52). Three days of alcohol exposure during this 
period resulted in subcortical white matter injury, as defined by microglia/macrophage 
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infiltration, axonal disruption, increased apoptosis, astrogliosis and altered glial cell 
morphology in 4/8 (50%) fetuses examined(19). Three of the remaining four fetuses 
demonstrated astrogliosis and increased apoptosis in cerebral white matter(19). Thus, 
7/8 (88%) alcohol-exposed fetuses showed evidence of white matter vulnerability to 
alcohol, which could induce CNS dysfunction; fetal control brains did not show any 
signs of overt injury. Importantly, there was a positive correlation between the maximal 
fetal PEC and the degree of white matter injury between fetuses(19). Other studies have 
demonstrated correlations between peak PEC and effects in offspring(61-64). The 
relationship between maximal PEC and effects on the fetal brain may explain the 
variability in brain injury that occurs in individuals with FASD(65). 
 
The effects of a prolonged period of daily alcohol exposure 
To determine the effects of a longer period of daily alcohol exposure on fetal 
development we infused alcohol from 95-133 days of gestation, with necropsy at 134 
days (term ~147 DGA). A similar protocol of daily maternal alcohol administration (0.75 
g/kg) was used as in the 3-day study to achieve a maximal PEC of ~0.11-0.12 g/dL (Fig. 
1).  
 
Physiological effects: When measured at 131-133 DGA, there were no significant 
effects of alcohol exposure on fetal heart rate (HR), MAP(18), electrocorticographic 
(ECoG) activity and sagittal sinus blood flow (unpublished observations). Prenatal 
alcohol exposure can initially impair fetal biophysical parameters, such as fetal 
breathing movements, electrooccular activity (EOG) and/or ECoG, in humans and 
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sheep(66, 67). However variables such as the gestational maturity of the fetus and the 
duration of alcohol exposure can impact upon biophysical parameters such as fetal 
breathing movements(67, 68), which may have occurred in our long term alcohol exposure 
model.  
 In relation to the start of the daily alcohol infusion maternal pH was decreased at 2-4 h, 
blood glucose concentration was decreased at 1-4 h and blood lactate concentration 
was increased at 1-6 h before returning to baseline values(18). In the fetus, there was a 
similar increase in blood lactate concentration at 4-10 h from the start of the daily 
alcohol infusion, whereas fetal pH and blood glucose concentration were unaffected(18). 
We further observed that fetal PaO2 and SaO2 were decreased at 10 h and 6-10 h, 
respectively, whereas maternal oxygenation was unaffected(18). All fetal arterial blood 
measurements returned to baseline values by 23 h after the end of the daily alcohol 
infusion(18).  
Fetal and maternal responses to daily alcohol infusion were more pronounced in this 
model of repeated alcohol exposure than in the 3-day exposure studies. This may be 
due to either the duration of maternal alcohol exposure or the greater gestational age of 
the fetus (131-133 vs 123 DGA) at the time of measuring responses. Our study showed 
for the first time that maternal daily alcohol exposure could cause delayed and 
prolonged changes in maternal and fetal homeostasis which could affect fetal 
development. Thus, the main physiological effects of this more prolonged daily 
exposure to alcohol were transient increases in maternal and fetal lactate 
concentrations, decreases in maternal blood glucose concentrations and pH and 
decreases in fetal oxygenation, effects not seen with the shorter (3 days) treatment. 
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Surprisingly, there was no evidence of fetal growth restriction after this longer (39 days) 
period of daily alcohol exposure; fetal body weight was not different between alcohol-
exposed and control groups at 134 DGA(18), or at birth when animals proceeded to 
term(60). In this latter group, postnatal growth up to nine weeks was also similar in the 
alcohol and control groups(60). In alcohol-exposed fetuses at 134 DGA, the ponderal 
index (body weight/crown-rump length3) was lower than in controls, indicating that these 
fetuses were thin relative to length(18). However, there was no decrease in ponderal 
index in the cohort of alcohol-exposed offspring that were born naturally at term, 
indicating that the prenatal reduction in body fat and/or muscle does not persist 
following the cessation of alcohol exposure at 133 DGA. Thus, fetal growth restriction 
was not a feature of this model of prolonged, daily alcohol exposure in late gestation. 
 
Brain development: The fetal brain was examined at 134 DGA following 39 days of 
alcohol exposure(18). Based on our previous finding that 3 days of alcohol exposure 
causes white matter injury(19), we expected that 39 days of exposure would result in 
more severe white matter injury. We evaluated astrocyte and microglia/macrophage 
density, percentages of activated microglia, myelinating oligodendrocytes and apoptotic 
cells, and the number of blood vessels per unit area of brain tissue, but found no 
differences between alcohol-exposed and control fetuses(18); although the presence of 
more subtle brain injury may have been revealed by the use of more quantitative 
methods (e.g. stereology). In 3/8 (38%) alcohol-exposed fetuses, there were small 
subarachnoid hemorrhages in the cerebral cortex and/or cerebellum (Fig 3)(18); we did 
not detect any hemorrhages in control fetal brains. Blood vessel rupture could be due to 
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changes in blood vessel wall composition and/or function, for which we have some 
evidence (see “small artery development” section). Cerebral hemorrhage following pre-
natal alcohol exposure, especially during development, could put the neonate at an 
increased risk of cerebral dysfunction, a key manifestation of the CNS injury of FAS and 
ARND(69). The differences seen in our 3 and 39 day alcohol models with respect to 
white matter injury and hemorrhage are worthy of further investigation, as they raise the 
possibility of white matter repair following initial alcohol exposure, but increasing risk of 
cerebrovascular injury with prolonged exposure .  
 
Small artery development: Direct application of alcohol to isolated smooth muscle 
cells from mature pig coronary arteries or intact coronary arteries results in an increase 
of intracellular Ca2+ and smooth muscle contraction(70). These effects are modified by 
the presence of the endothelium, indicating complex interactions of alcohol with 
vascular tissue that include smooth muscle contraction via increases in intracellular free 
Ca2+ and endothelial release of vasodilator agents. 
Little is known of the effects of alcohol exposure during pregnancy on the development 
of the vascular system. Although vascular development begins early, it is not until very 
late in gestation and early postnatal life that collagen and elastin (which provide strength 
and elasticity in vessel walls) reach maximal production(71, 72). Alterations to blood 
vessel wall structure, such as changes in collagen and elastin content or in extracellular 
matrix cross-linking, can alter endothelial and smooth muscle function and arterial wall 
stiffness(73). In pregnant sheep a long (30-82 days gestation) exposure to a relatively 
high level of alcohol (maximal PEC of ~0.22 g/dL) once a day (5 days on, 2 days off) 
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resulted in increased cerebrovascular relaxation responses when isolated vessels were 
tested in vitro(74). In human umbilical arteries taken from newborn infants exposed to 
alcohol during pregnancy (17-20 standard drinks per trimester), endothelium-dependent 
relaxation was not affected, but the sensitivity of smooth muscle cells to 
vasoconstrictors was reduced(75). Furthermore, nine-year-old children, exposed to 
alcohol in utero but not diagnosed with FASD, had increased aortic wall stiffness when 
compared with control children(76); increased arterial wall stiffness is a clinical predictor 
of cardiovascular disease(77). Together, these studies indicate that prenatal alcohol 
exposure effects arterial function and stiffness which persist into childhood and may be 
the early expression of vascular dysfunction leading to cardiovascular disease in later 
life.  
We have examined passive mechanical properties and endothelial and smooth muscle 
function in fetal and postnatal small arteries from five vascular beds (cerebral, coronary, 
renal, femoral and mesenteric) following daily alcohol exposure for 39 days during late 
gestation. At 134 DGA and nine weeks after birth, we observed widespread changes in 
endothelial and smooth muscle function and passive mechanical properties, including 
arterial wall stiffness(78-81). The changes that we observed in vascular function and 
vessel wall mechanics differed between vessels, and also differed between the fetus 
and postnatal lamb. Changes observed in endothelial and smooth muscle function and 
arterial wall stiffness in arteries from the brain, heart and kidneys are summarised in 
Table 1. These changes, if they persist into later life are likely to alter cardiovascular 
function and increase the risk of cardiovascular disease; for this reason they are the 
subject of on-going investigation. Changes in arterial mechanics and function could 
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explain the cerebral hemorrhages that we observed in some fetuses after 39 days of 
alcohol exposure. Importantly, such changes could have serious consequences if they 
persist into postnatal life; the effects of challenges, such as exercise or stress, may 
further exacerbate the cardiovascular phenotype. Arterial dysfunction can restrict 
regional blood flow, suggesting that key organs such as the brain, kidneys and heart 
may be at increased risk of damage following alcohol exposure in late gestation.  
 
Heart development: The fetal heart was the only organ in which we observed evidence 
of altered growth following 39 days of daily alcohol exposure. In this study, we observed 
that the fetal heart-to-body weight ratio was greater in alcohol-exposed fetuses than in 
controls(57). Specifically, there was a greater left ventricular and septal wall volume in 
alcohol-exposed fetuses(57). This left ventricular hypertrophy was attributed to an 
increase in cardiomyocyte size and a 12% increase in the proportion of mature, 
binucleated cardiomyocytes relative to immature, mononucleated cardiomyocytes (Fig 
4)(57). The stimulus for the increase in heart growth appears to be a direct trophic effect 
on the cardiomyocytes rather than a hemodynamic effect, as fetal and postnatal MAP 
were not affected. Other drugs, including angiotensin II, have been found to induce 
cardiac hypertrophy in the absence of hemodynamic changes(82).  
Toxicants including cocaine and acetaldehyde (the principal metabolite of ethanol) have 
also been shown to induce cardiac hypertrophy(83). In vitro studies show that alcohol 
exposure can increase the number of mature cardiomyocytes by increasing the number 
of cells in the GO/G1 phase of the cell cycle (indicative of mature cells that have exited 
the cell cycle)(84), which is consistent with the findings of our in vivo pregnant sheep 
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study. As mature binucleated cardiomyocytes are larger than immature mononucleated 
cardiomyocytes (Fig 4B), the increased proportion of binucleated cardiomyocytes likely 
contributes to the overall increase in left ventricular and septal size in the alcohol-
exposed lambs. In addition, mRNA expression of the cardiomyocyte growth factor IGF-1 
was increased in alcohol-exposed fetal hearts, which may also contribute to the 
increased size of the cardiomyocytes(57).  
We observed an increase in the mRNA expression of the pro-apoptotic genes (caspase 
3 and BAX) in the alcohol-exposed hearts(57). Alcohol exposure during pregnancy in rats 
can increase the expression of markers of cardiomyocyte apoptosis, decrease the heart 
to body weight ratio and increase cardiac contractile function in offspring(85). However in 
our model the increase in caspase-3 and BAX mRNA expression was not associated 
with an increase in cardiac cell death. The functional consequences of these effects on 
cardiomyocyte growth and subsequent left ventricular hypertrophy remain to be 
investigated.  
 
Kidney development: An examination of the fetal kidney at 134 DGA following 
prolonged (39 days) alcohol exposure during late gestation revealed no overt signs of 
renal injury or changes in kidney weight or glomerular volume(58). Furthermore, there 
were no differences in mRNA expression of several key genes responsible for kidney 
development and function such as the renin-angiotensin system, IGFs, and sodium 
transporters(58). Renal function was not assessed in this study, but amniotic fluid 
composition, which can be used as an indicator of fetal renal function, showed no 
differences between control and alcohol-exposed groups with respect to concentrations 
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of Na+, K+, Cl-, creatinine, urea, uric acid and total protein, suggesting that fetal renal 
function was not overtly compromised.  
Nephrogenesis is normally complete by 120-130 DGA in sheep(53), and so we were able 
to assess the effects of the prolonged alcohol exposure on final nephron number. We 
observed that total nephron number was decreased by 11% in the alcohol-exposed 
fetuses (Fig 5)(58). This reduction may have been due to a reduction in renal branching 
morphogenesis, which is actively occurring at ~100 DGA in the fetal sheep(53), as 
alcohol has been shown to reduce branching in organ-culture studies of kidney(86). As 
no new nephrons are produced following the completion of nephrogenesis, it is 
expected that the observed reduction in nephron number will persist into postnatal life. 
Previous studies have shown that a reduction of 20-30% in nephron number is 
associated with elevated blood pressure in later life in sheep(87) and rodents(88-90), but it 
is unclear what effects an 11% reduction in nephron number will have on blood 
pressure in later life. As mentioned previously, there was no difference in MAP or HR in 
our alcohol-exposed nine-week-old lambs compared with controls(57). However in rats, 
two doses of alcohol, resulting in similar maximal PEC and nephron deficit to that 
obtained in our study, resulted in elevated blood pressure in offspring at 6 months of 
age(91). Potentially, a small decrease in nephron number when combined with other 
cardiovascular risk factors, such as obesity and/or a poor diet, could increase the risk of 
hypertension in later life.  
 
Lung development: In sheep as in humans, lung development predominantly occurs in 
utero, but continues after birth. In both species, alveolarization begins during late 
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gestation and continues into postnatal life(55, 56); however, in sheep it is likely that a 
greater proportion of the final number of alveoli are formed before birth than in humans. 
Repeated daily alcohol exposure did not alter lung morphology or growth in our fetuses 
at 134 DGA or in postnatal lambs at nine weeks of age(59, 60). We observed an increase 
in collagen Iα1 mRNA and an increase in collagen protein deposition in fetal lungs, 
which could affect lung compliance; although this increase in collagen did not persist 
postnatally(59, 60), if present at term or preterm birth, it could affect lung compliance at the 
onset of gaseous ventilation. We also measured mRNA expression of pro-inflammatory 
cytokines and observed that IL-1β and interleukin 8 (IL-8) mRNA expressions were 
reduced in the fetal lungs; however, there was no change in cytokine mRNA expression 
at nine weeks after birth(59, 60). The alcohol-induced reductions in fetal IL-1β and IL-8 
mRNA expression suggest impairment in the innate immune status of the lung during 
development which could affect the ability of the lung to clear pathogens. 
Lung surfactant comprises ~90% lipids (90-95% of which are phospholipids) and ~10% 
surfactant proteins, and acts to decrease surface tension and to assist in the immune 
response to respiratory pathogens. In amniotic fluid collected at 134 DGA, we observed 
that 39 days of alcohol exposure led to an overall decrease in phospholipid 
concentration, with a decrease in the proportion of the phospholipids, 
phosphatidylserine (PS), phosphatidylglycerol (PG) and phosphatidylethanolamine (PE) 
(Fig. 6)(60). Amniotic fluid is comprised of fetal lung liquid and fetal urine and thus 
changes in lung liquid secretion rates, fetal swallowing and/or fetal urine production and 
could account for the decrease in the proportion of phospholipids. Such a change in 
phospholipids could result in increased surface tension in the lung, which could 
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contribute to respiratory distress at birth; however, alcohol-exposed lambs that were 
born at term (approximately 12 days after the final maternal alcohol infusion), showed 
no respiratory dysfunction at birth. The proportion of phosphatidylcholine (PC), which is 
the major phospholipid in surfactant and is involved in decreasing surface tension, was 
increased in amniotic fluid taken from alcohol-exposed fetuses; this may have 
compensated, in part, for the reduced phospholipid concentration(60). In bronchoalveolar 
lavage fluid from postnatal lambs, surfactant phospholipid composition was not different 
from that of controls(60), suggesting that recovery of surfactant production occurs after 
alcohol exposure is discontinued. 
Surfactant proteins (SP)-A and SP-D have immunoregulatory roles, whilst SP-B and 
SP-C help to decrease surface tension in the lung. The gene expression of SP-A and 
SP-B was reduced in fetal lung tissue(60) suggesting that the innate immunity of fetal 
lung may be compromised and lung compliance may be reduced. In nine-week-old 
alcohol-exposed lambs the mRNA expression of SP-D was increased in lung tissue 
(Fig. 7)(60). This increase in SP-D may be associated with an increased pro-
inflammatory state, since previous studies have shown that SP-D not only controls pro-
inflammatory responses(92), but SP-D expression can be stimulated by an increase in 
pro-inflammatory cytokines(93). Furthermore, SP-D can control T-helper (Th)2-type 
inflammation in the airways and hence is involved in regulating allergic airway 
inflammation(94). Given the known roles of SP-D in controlling pulmonary immunity, 
further studies are required to determine if susceptibility to infection and allergic 
sensitization is affected by prenatal ethanol exposure later in life. The alcohol-induced 
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changes that we observed in the innate immune status of the fetal and postnatal lung 
may alter the risk of lung infection after birth, and warrant further investigation. 
 
Relevance of the pregnant sheep models to FASD and FAS 
In the 3 day alcohol model, alcohol-exposed fetuses were lighter than controls. 
However, neither fetal nor postnatal growth restriction occurred in our 39 day maternal 
alcohol administration model, with a reduction in ponderal index, but not body weight, 
observed at 134 DGA. The lack of persistent IUGR may indicate that placental function 
or maternal nutrition were not seriously affected by the alcohol protocol that we used. 
Structurally, many of the organs collected at necropsy were not different. Indeed, the 
only organ grossly affected was the fetal heart, which displayed signs of left ventricular 
hypertrophy that was attributed to an increase in cardiomyocyte size or maturity, rather 
than in the number of cardiomyocytes. We observed white matter injury in the 3 day 
alcohol model, but there was less evidence of overt cerebral injury in the 39 day model. 
Therefore, our exposure regimen of ~3-4 standard U.S.A drinks over 1h for 39 days in 
late gestation appears to reflect the more subtle effects associated with FASD, rather 
than the more severe phenotype of FAS.  
Repeated maternal alcohol administration decreased maternal blood glucose 
concentration and arterial pH, and increased blood lactate concentration(18). In the fetus, 
these alcohol treatments caused increased blood lactate concentration and decreased 
arterial oxygenation(18). Such changes in arterial blood composition were not seen in the 
3-day alcohol-exposure study, which may be the result of the shorter sampling protocol 
used in the 3 day study. It is likely that the changes observed in blood lactate and pH 
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were caused by the metabolism of alcohol or acetaldehyde, the major metabolite of 
alcohol metabolism. Our finding that alcohol-exposure resulted in a mild reduction in 
fetal blood oxygenation beginning at 6 h from infusion onset is novel and suggests a 
modest impairment of placental function, perhaps as a result of acetaldehyde or other 
metabolites, as the PEC in both the ewe and fetus was negligible at this time(18). The 
presence of only mild hypoxemia following prolonged alcohol exposure is consistent 
with our failure to detect IUGR and more overt structural changes in the fetal brain, 
which might have been expected if more profound chronic fetal hypoxemia had 
occurred. 
 
Pre-natal alcohol exposure in late gestation and cardiovascular risk 
Prenatal alcohol exposure may affect heart and vascular development, thereby 
increasing the risk of cardiovascular disease in offspring. We observed that fetal alcohol 
exposure inhibited nephrogenesis, and together with left ventricular hypertrophy and 
altered small artery wall stiffness and function, these changes could impact adversely 
on systemic cardiovascular function in later life. Prolonged daily fetal alcohol exposure 
was also associated with cerebral haemorrhage, which suggests alterations in cerebral 
artery structure and/or function. Currently, there are no data on the prevalence of 
cardiovascular disease in older individuals affected by FASD. However one study has 
suggested an association between FAS and mid-aortic syndrome, which is an 
uncommon syndrome characterised by the narrowing of the abdominal aortic walls and 
branches resulting in hypertension(95). Based on our findings, the risk of cardiovascular 
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disease in individuals exposed to alcohol prenatally in late gestation could be increased, 
and this should be a focus of future epidemiological studies. 
 
Prenatal alcohol exposure in late gestation and the risk of compromised 
pulmonary immunity 
Our findings that prenatal alcohol exposure altered surfactant in the fetal lung are 
consistent with other studies in sheep(96, 97). In our model, we observed an 80% increase 
in SP-D mRNA expression in alcohol-exposed nine-week-old lambs(60). SP-D primarily 
acts to protect the lungs from airborne pathogens by maintaining innate immunity in the 
lung; such an increase in SP-D could enhance the innate immunity of the lung. It is 
possible that our observed increase in SP-D in postnatal lambs may be a response to 
an overall reduction in pulmonary immune function following prenatal alcohol exposure. 
This speculation is supported by our finding that SP-A mRNA expression in lung tissue 
of alcohol-exposed fetuses was ~1/3 of control levels at 134 DGA, suggesting a 
compromised fetal immune status(59). The expression of SP-A, which also plays an 
immunoregulatory role, and IL-1β and IL-8 mRNA were decreased in the fetal lungs(59) 
and TNF-α mRNA expression was increased in the placenta(98). It is unclear what effect 
these changes could have on overall immunity, but they may result in postnatal changes 
to immune function which could increase the risk of infection. Children with FAS are 
known to suffer more frequently from respiratory and other infections(99, 100). 
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Alcohol dosing regimen and cerebral injury 
The 3 day maternal alcohol administration protocol showed that 7/8 fetuses had some 
form of brain injury(19). Surprisingly however, following 39 days of alcohol exposure, we 
found little evidence of brain injury, although subarachnoid and cerebellar hemorrhages 
were observed(18). This finding is interesting as it suggests that grey and white matter in 
the fetal brain may adapt to episodic, long-term exposure to alcohol, but cerebral blood 
vessels may become progressively more vulnerable to damage. The molecular basis of 
these putative repair, adaptation, and cerebrovascular changes are currently unknown, 
and further investigation is clearly needed. 
 
Conclusions 
Based on our findings, it appears that moderate, daily maternal alcohol consumption 
during late gestation can cause a wide range of subtle effects on the fetal brain, heart, 
small arteries, lungs and kidneys, some of which persist after birth. It appears that fetal 
adaptation to repeated alcohol exposure can occur. Our data, together with those of 
other studies, suggest that the cardiovascular and immune systems may be at higher 
risk of dysfunction in postnatal life. Additional research into the long-term cardiovascular 
and immunological effects of moderate prenatal alcohol exposure, particularly when 
challenged by lifestyle factors and infection, is warranted. It is important to recognize 
that many of the changes we have observed in fetal organ development will likely have 
long-term effects on health and disease during postnatal life. In order to fully understand 
the effects of alcohol exposure on the developing fetus it is essential to examine 
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multiple organs at the microscopic and molecular levels. Finally, in view of our findings, 
pregnant women should be advised to abstain from consuming alcohol. 
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Figure legends 
Figure 1: Maternal and fetal plasma ethanol concentration (PEC) over time in relation to 
infusion onset. Shaded area indicates the administration of the 1 hour daily infusion 
(0.75 g/maternal kg). *p<0.05 between alcohol and control cohorts. Reproduced and 
adapted with permission of the publisher (Kenna et. al., 2011). 
 
Figure 2: The experimental protocols used in our three studies of fetal alcohol exposure 
in late gestation. Alcohol (1 g/maternal kg in study 1; 0.75 g/maternal kg in studies 2 
and 3) was administered for 1 hour daily over the alcohol infusion period. DGA: Days of 
gestational age. Term is equivalent to ~147 DGA. 
 
Figure 3: Subarachnoid (A - C) and cerebellar hemorrhages (D - F) following 39 days of 
daily alcohol (0.75 g / kg of maternal weight) exposure in late gestation (95-134 days of 
gestation). Hematoxylin and eosin (H&E) stained section of the cerebrum hemisphere 
(A) shows a subarachnoid hemorrhage. The square in (A) is magnified to demonstrate 
(B) astroglial (Glial fibrillary acidic protein (GFAP)) and (C) microglial (ionized calcium 
binding adaptor molecule 1 (IBA-1)) responses surrounding the hemorrhage. H&E 
section of the cerebellar hemisphere (D) shows a parenchymal hemorrhage and 
subsequent damage to the cerebellar cortex. The parachymal hemorrhage is also 
associated with astroglial (GFAP; E) and microglial (IBA-1; F) responses. Scale bars: 
(A) 200µm, (B - F) 100µm. Reproduced with permission of the publisher (Kenna et al, 
2011). 
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Figure 4: Percentage of binucleated (A) cardiomyocytes within the left ventricle and 
septum in saline and EtOH-exposed fetal hearts at 134 days of gestation following 1 
hour daily alcohol (0.75 g/maternal kg) infusions from 95-133 DGA.  *p<0.05 between 
alcohol and control cohorts. Representative left ventricular section (B) showing mono-
nucleated (smaller) and bi-nucleated (larger) cardiomyocytes (yellow arrows). 
Cardiomyocytes are stained with wheat germ agglutinin-Alexa Fluor 488 (green) and 
TO-PRO-3 (blue). Scale bar = 8 µm. Reproduced and adapted with permission of the 
publisher (Goh et. al., 2010). 
 
Figure 5: Total nephron number in saline and EtOH-exposed fetal kidneys at 134 days 
of gestation after 39 days of daily 1 hour EtOH infusions (0.75 g/kg of maternal weight). 
*p<0.05 between alcohol and control cohorts. Reproduced and adapted with permission 
of the publisher (Gray et. al., 2008).  
 
Figure 6: Surfactant phospholipid component concentrations (A) and relative 
percentages of surfactant phospholipid classes (B) in amniotic fluid at 134 days of 
gestation following 39 days of daily alcohol (0.75 g /maternal kg) infusions. Phospholipid 
classes: phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylcholine (PC), 
phosphatidylglycerol (PG) and phosphatidylethanolamine (PE). *p<0.05 between 
alcohol and control cohorts. Reproduced and adapted with permission of the publisher 
(Sozo et. al., 2011). 
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Figure 7: Surfactant protein mRNA expression levels (SP-A (A), SP-B (B), SP-C (C) 
and SP-D (D)) in 9 week old lamb lung tissue from controls or fetuses exposed to daily 
1 hour alcohol (0.75 g / maternal kg) infusions for 39 days during late gestation (95-133 
DGA). *p<0.05 between alcohol and control cohorts. Reproduced and adapted with 
permission of the publisher (Sozo et. al., 2011). 
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